Page last updated: 2024-11-02

orphenadrine and Thoracic Outlet Syndrome

orphenadrine has been researched along with Thoracic Outlet Syndrome in 1 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Thoracic Outlet Syndrome: A neurovascular syndrome associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the superior thoracic outlet. This may result from a variety of anomalies such as a CERVICAL RIB, anomalous fascial bands, and abnormalities of the origin or insertion of the anterior or medial scalene muscles. Clinical features may include pain in the shoulder and neck region which radiates into the arm, PARESIS or PARALYSIS of brachial plexus innervated muscles, PARESTHESIA, loss of sensation, reduction of arterial pulses in the affected extremity, ISCHEMIA, and EDEMA. (Adams et al., Principles of Neurology, 6th ed, pp214-5).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
von Albert, HH1

Other Studies

1 other study available for orphenadrine and Thoracic Outlet Syndrome

ArticleYear
[Therapy in neurology. 10. The cervical syndrome--shoulder-neck-arm pain].
    Fortschritte der Medizin, 1982, May-13, Volume: 100, Issue:18

    Topics: Cervical Rib Syndrome; Chlormezanone; Diagnosis, Differential; Humans; Muscular Atrophy; Orphenadrin

1982